Abbott Reports First-Quarter 2020 Results

Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: PR Newswire
ABBOTT PARK, Ill., April 16, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2020.First-quarter worldwide sales of $7.7 billion increased 2.5 percent on a reported basis and 4.3 percent on an organic* basis. Reported diluted EPS from continuing operations under GAAP was $0.30 and adjusted diluted EPS from continuing operations, which excludes specified items, was $0.65 in the first quarter. Due to uncertainties regarding the duration and impact of the coronavirus (COVID-19) pandemic, Abbott is suspending its previously announced annual guidance for 2020. Abbott's strong financial position is supported by a healthy balance sheet, including approximately $3.7 billion in cash, cash equivalents and short-term investments, and revolving credit facilities in place that could provide additional access to up to $5 billion, if needed. Abbott recently launched three diagnostics tests for COVID-19, including molecular tests on its I
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Global Cardiac Biomarkers Diagnostics Industry Research 2024-2029: Rising Prevalence of CVD and High Sensitivity POCT Driving Transformational Growth [Yahoo! Finance]Yahoo! Finance
- Point of Care Diagnostics Market Analysis, Growth Trends and Forecast Report 2025-2033: Advancements in Diagnostics and Accessibility Drive Growth in Healthcare Testing Solutions [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (ABT): Among the Best Drug Stocks to Buy Now [Yahoo! Finance]Yahoo! Finance
- If You Invested $10,000 In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now? [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/25 - In-Line
ABT
Sec Filings
- 2/7/25 - Form 4
- 2/5/25 - Form 144
- 1/31/25 - Form 4
- ABT's page on the SEC website